ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE u-turn approves funding for rare disease therapy Crysvita
pharmatimes
September 14, 2018The National Institute for Health and Care Excellence (NICE) has changed its position on NHS funding for Kyowa Kirin International’s Crysvita... -
NICE rejects Alexion’s rare disease therapy Kanuma
pharmatimes
February 16, 2017The National Institute for Health and Care Excellence has published a final evaluation determination rejecting the use of Alexion's Kanuma to treat infants, children and adults with the rare inherited genetic disorder lysosomal acid lipase deficiency (LAL
Pharma Sources Insight January 2025
